These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 9085317

  • 21. Pharmacokinetics and pharmacodynamics of saquinavir in pediatric patients with human immunodeficiency virus infection.
    Grub S, Delora P, Lüdin E, Duff F, Fletcher CV, Brundage RC, Kline MW, Calles NR, Schwarzwald H, Jorga K.
    Clin Pharmacol Ther; 2002 Mar; 71(3):122-30. PubMed ID: 11907486
    [Abstract] [Full Text] [Related]

  • 22. Lack of an effect of oral iron administration on mycophenolic acid pharmacokinetics in stable renal transplant recipients.
    Gelone DK, Park JM, Lake KD.
    Pharmacotherapy; 2007 Sep; 27(9):1272-8. PubMed ID: 17723081
    [Abstract] [Full Text] [Related]

  • 23. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers.
    Penn R, Williams RX, Guha-Ray DK, Sawyers WG, Braun SL, Rains KT.
    Clin Ther; 2006 Jan; 28(1):45-54. PubMed ID: 16490579
    [Abstract] [Full Text] [Related]

  • 24. Influence of morning or evening administration on absorption of theophylline.
    Su YM, Cheng TP, Yeh TW, Wen CY, Wang DI.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
    [Abstract] [Full Text] [Related]

  • 25. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
    Kapil R, Nolting A, Roy P, Fiske W, Benedek I, Abramowitz W.
    Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765
    [Abstract] [Full Text] [Related]

  • 26. Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis.
    Gibson RL, Retsch-Bogart GZ, Oermann C, Milla C, Pilewski J, Daines C, Ahrens R, Leon K, Cohen M, McNamara S, Callahan TL, Markus R, Burns JL.
    Pediatr Pulmonol; 2006 Jul; 41(7):656-65. PubMed ID: 16703579
    [Abstract] [Full Text] [Related]

  • 27. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
    O'Farrell AM, van Vliet A, Abou Farha K, Cherrington JM, Campbell DA, Li X, Hanway D, Li J, Guler HP.
    Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
    Henney HR, Shah J.
    Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis.
    Deterding R, Retsch-Bogart G, Milgram L, Gibson R, Daines C, Zeitlin PL, Milla C, Marshall B, Lavange L, Engels J, Mathews D, Gorden J, Schaberg A, Williams J, Ramsey B, Cystic Fibrosis Foundation Therapeutics Development Network.
    Pediatr Pulmonol; 2005 Apr; 39(4):339-48. PubMed ID: 15704203
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Pilot study of amiloride inhalation in children with cystic fibrosis].
    Riedler J, Huttegger I.
    Klin Padiatr; 1992 Apr; 204(3):158-62. PubMed ID: 1614182
    [Abstract] [Full Text] [Related]

  • 36. Buccal delivery of an alpha 2-adrenergic receptor antagonist, atipamezole, in humans.
    Huupponen R, Karhuvaara S, Anttila M, Vuorilehto L, Scheinin H.
    Clin Pharmacol Ther; 1995 Nov; 58(5):506-11. PubMed ID: 7586944
    [Abstract] [Full Text] [Related]

  • 37. Tolerability and pharmacokinetic properties of ciprofloxacin dry powder for inhalation in patients with cystic fibrosis: a phase I, randomized, dose-escalation study.
    Stass H, Weimann B, Nagelschmitz J, Rolinck-Werninghaus C, Staab D.
    Clin Ther; 2013 Oct; 35(10):1571-81. PubMed ID: 24054830
    [Abstract] [Full Text] [Related]

  • 38. Multiple-dose pharmacokinetics of fluvoxamine in children and adolescents.
    Labellarte M, Biederman J, Emslie G, Ferguson J, Khan A, Ruckle J, Sallee R, Riddle M.
    J Am Acad Child Adolesc Psychiatry; 2004 Dec; 43(12):1497-505. PubMed ID: 15564819
    [Abstract] [Full Text] [Related]

  • 39. Absorption kinetics of orally administered leucovorin calcium.
    McGuire BW, Sia LL, Haynes JD, Kisicki JC, Gutierrez ML, Stokstad EL.
    NCI Monogr; 1987 Dec; (5):47-56. PubMed ID: 3501546
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.